The FDA just expanded a landmark gene therapy to children as young as 2. Here's what Casgevy actually does, and why the age expansion matters.
Jul 12, 2026
•
5 min read
The first person to receive stem cell therapy for Huntington's disease was treated last month. Here is exactly what we know, and what we don't.
Jul 3, 2026
A 12-person Chicago trial just put every participant off insulin. What that result means, what it doesn't, and why it matters to stem cell therapy.
Jun 19, 2026
